Microcalcification crystallography as a potential marker of DCIS recurrence

Autor: Gosling, Sarah B, Arnold, Emily L, Davies, Samantha K, Cross, Hannah, Bouybayoune, Ihssane, Calabrese, Doriana, Nallala, Jayakrupakar, Pinder, Sarah E, Fu, Liping, Lips, Esther H, King, Lorraine, Marks, Jeffrey, Hall, Allison, Grimm, Lars J, Lynch, Thomas, Pinto, Donna, Stobart, Hilary, Hwang, E Shelley, Wesseling, Jelle, Geraki, Kalotina, Stone, Nicholas, Lyburn, Iain D, Greenwood, Charlene, Rogers, Keith D, Grand Challenge PRECISION Consortium

Ductal carcinoma in-situ (DCIS) accounts for 20-25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers may result in relatively high levels (~ 75%) of overtreatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______109::ffae27cbff03382477ee8dc25e4976fc
https://www.repository.cam.ac.uk/handle/1810/353614

Microcalcification crystallography as a potential marker of DCIS recurrence.

Autor: Gosling SB; School of Chemical and Physical Sciences, Keele University, Keele, UK. s.b.gosling@keele.ac.uk., Arnold EL; Cranfield Forensic Institute, Cranfield University, Shrivenham, UK., Davies SK; Cranfield Forensic Institute, Cranfield University, Shrivenham, UK., Cross H; School of Chemical and Physical Sciences, Keele University, Keele, UK., Bouybayoune I; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK., Calabrese D; School of Physics and Astronomy, University of Exeter, Exeter, UK., Nallala J; School of Physics and Astronomy, University of Exeter, Exeter, UK., Pinder SE; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK., Fu L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., King L; Department of Surgery, Duke University Medical Center, Durham, NC, UK., Marks J; Department of Surgery, Duke University Medical Center, Durham, NC, UK., Hall A; Department of Pathology, University of British Colombia, Vancouver, BC, Canada., Grimm LJ; Department of Radiology, Duke University, Durham, NC, UK., Lynch T; Department of Surgery, Duke University Medical Center, Durham, NC, UK., Pinto D; DCIS411.com, San Diego, CA, USA., Stobart H; Independent Cancer Patients' Voice, London, UK., Hwang ES; Department of Surgery, Duke University Medical Center, Durham, NC, UK., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Divisions of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Geraki K; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK., Stone N; School of Physics and Astronomy, University of Exeter, Exeter, UK., Lyburn ID; Cranfield Forensic Institute, Cranfield University, Shrivenham, UK.; Thirlestaine Breast Centre, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, Gloucestershire, UK.; Cobalt Medical Charity, Cheltenham, UK., Greenwood C; School of Chemical and Physical Sciences, Keele University, Keele, UK., Rogers KD; Cranfield Forensic Institute, Cranfield University, Shrivenham, UK. k.d.rogers@cranfield.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2023 Jun 08; Vol. 13 (1), pp. 9331. Date of Electronic Publication: 2023 Jun 08.